NCT00221052已完成不适用
Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men
TNO2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2005年6月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 2
研究概览
简要总结
Overweight increases the risk to develop chronic diseases including type-2 diabetes and cardiovascular disease. The low-grade inflammatory status often seen in overweight subjects is thought to play an important role in disease development.
The purpose of this study is to determine the role of inflammation on glucose metabolism and insulin resistance. In this study the effect of the anti-inflammatory treatment diclofenac on markers of inflammation and on parameters of glucose metabolism will be studied.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Body Mass Index (BMI): 25.1 - 32.0 kg/m2
- •Normal Dutch eating habits
排除标准
- •diabetes, cardiovascular disease or hypertension
- •Not suitable to receive diclofenac treatment
- •Extreme physical activity (more than 6 hours/week)
- •Reported slimming or medically prescribed diet
研究者
研究点 (2)
Loading locations...
相似试验
招募中
1 期
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial FunctionMetabolic SyndromeObesityNCT05972564Vanderbilt University Medical Center74
已完成
不适用
Inflammation and the Metabolic Syndrome in HumansMetabolic Syndrome XNCT00954824University of Pennsylvania50
已完成
不适用
Study of Immune Response in Obesity and Type 2 DiabetesHealthy VolunteersObesityType 2 DiabetesNCT01907399Centre Hospitalier Universitaire Dijon101
已完成
1 期
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity PilotPre-diabetesObesityNCT04907214Vanderbilt University Medical Center29
已完成
不适用
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal ObesityGrowth HormoneObesityNCT00562796Massachusetts General Hospital149